Free Access
Med Sci (Paris)
Volume 17, Number 12, Décembre 2001
Page(s) 1270 - 1275
Section Articles de Synthèse
Published online 15 December 2001
  1. Karsenty G. The genetic transformation of bone biology. Genes Dev 1999; 13 : 3037–51. [Google Scholar]
  2. Manolagas SC. Birth and death of bone cells : basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrinol Rev 2000; 2 : 115–37. [Google Scholar]
  3. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin : a novel secreted protein involved in the regulation of bone density. Cell 1997; 89 : 309–19. [Google Scholar]
  4. Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12 : 1260–8. [Google Scholar]
  5. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93 : 165–76. [Google Scholar]
  6. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999; 397 : 315–23. [Google Scholar]
  7. Poli V, Balena R, Fattori E, et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994; 5 : 1189–96. [Google Scholar]
  8. Couse JF, Korach KS. Estrogen receptor null mice : what have we learned and where will they lead us ? Endocrinol Rev 1999; 3 : 358–417. [Google Scholar]
  9. Potts JT, and Juppner H. Parathyroid hormone and parathyroid hormone-related peptide in calcium homeostasis, bone metabolism and bone development : the proteins, their genes, and receptors In : Avioli LV, Krane SM, eds. Metabolic bone disease and clinically related disorders. San Diego; Academic Press, 1998. [Google Scholar]
  10. Nicholson GC, Moseley JM, Sexton PM, et al. Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest 1986; 2 : 355–60. [Google Scholar]
  11. Ducy P, Starbuck M, Priemel M, et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 1999; 13 : 1025–36. [Google Scholar]
  12. Corral DA, Amling M, Priemel M, et al. Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proc Natl Acad Sci USA 1998; 95 : 13835–40. [Google Scholar]
  13. Felson DT, Zhang Y, Hannan MT, et al. Effects of weight and body mass index on bone mineral density in men and women: The Framingham study. J Bone Miner Res 1993; 8 : 567–73. [Google Scholar]
  14. Ravn P, Cizza G, Bjarnason NH, et al. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women early postmenopausal intervention cohort (EPIC) study group. J Bone Min Res 999; 14 : 1622–7. [Google Scholar]
  15. Riggs BL, Melton LJ3d: involutional osteoporosis. N Engl J Med 1986; 314 : 1676–86. [Google Scholar]
  16. Riggs BL, Khosla S, Melton LJ.3rd. A unitary model for involutional osteoporosis : estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998; 13 : 763–73. [Google Scholar]
  17. Tremollieres FA, Pouilles JM, Ribot C. Vertebral post-menopausal bone loss is reduced in overweight women : a longitudinal study in 155 early postmenopausal women. J Clin Endocrinol Metab 1993; 77 : 683–6. [Google Scholar]
  18. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395 : 763–70. [Google Scholar]
  19. Spiegelman BM, Flier JS. Adipogenesis and obesity : rounding out the big picture. Cell 1996; 87 : 377–89. [Google Scholar]
  20. Chen H, Charlat O, Tartaglia LA, et al. Evidence that the diabetes gene encodes the leptin receptor : identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996; 84 : 491–5. [Google Scholar]
  21. Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392 : 398–401. [Google Scholar]
  22. Lee GH, Proenca R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379 : 632–5. [Google Scholar]
  23. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387 : 903–8. [Google Scholar]
  24. Strobel A, Issad T, Camoin L, et al. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998; 3 : 213–5. [Google Scholar]
  25. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83 : 1263–71. [Google Scholar]
  26. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue Nature 1994; 372 : 425–32 et 1995; 374 : 479 (erratum). [Google Scholar]
  27. Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay : a central control of bone mass. Cell 2000; 2 : 197–207. [Google Scholar]
  28. Dinulescu DM, Cone RD. Agouti and agouti-related protein : analogies and contrasts. J Biol Chem 2000; 275 : 6695–8. [Google Scholar]
  29. Lu D, Willard D, Patel IR, et al. Agouti protein is an antagonist of the melanocyte-stimulating-hromone receptor. Nature 1994; 371 : 799–802. [Google Scholar]
  30. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry : standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res 1987; 6 : 595–610. [Google Scholar]
  31. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382 : 25052. [Google Scholar]
  32. Reid IR. Preventing glucocorticoid-induced osteoporosis. N Engl J Med 1997; 337 : 420–1. [Google Scholar]
  33. Thomas T, Gori F, Khosla S, et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999; 140 : 1630–8. [Google Scholar]
  34. Baumann H, Morella KK, White DW, et al. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci USA 1996; 93 : 8374–5. [Google Scholar]
  35. Elmquist JK, Ahima RS, Maratos-Flier E, et al. Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 1997; 138 : 839–42. [Google Scholar]
  36. Ghilardi N, Ziegler S, Wiestner A, et al. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 1996; 93 : 6231–5. [Google Scholar]
  37. Moitra J, Mason MM, Olive M, et al. Life without white fat : a transgenic mouse. Genes Dev 1998; 12 : 3168–81. [Google Scholar]
  38. Vaisse C, Halaas JL, Horvath CM, et al. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 1996; 14 : 95–7. [Google Scholar]
  39. Ahn S, Olive M, Aggarwal S, et al. A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol Cell Biol 1998; 2 : 967–77. [Google Scholar]
  40. Levy JB, Schindler C, Raz R, et al. Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells. Endocrinology 1996; 137 : 1159–65. [Google Scholar]
  41. Bellido T, Stahl N, Farruggella TJ, et al. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J Clin Invest 1996; 2 : 431–7. [Google Scholar]
  42. Westvik J. Radiological features in generalized lipodystrophy. Acta Paediatr 1996; 413 (suppl) : 44–51. [Google Scholar]
  43. Halaas JL, Boozer C, Blair-West J, et al. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 1997; 94 : 8878–83. [Google Scholar]
  44. Elmquist JK, Elias CF, Saper CB. From lesions to leptin : hypothalamic control of food intake and body weight. Neuron 1999; 2 : 221–32. [Google Scholar]
  45. Marsh DJ, Hollopeter G, Huszar D, et al. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet 1999; 1 : 119–22. [Google Scholar]
  46. Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996; 274 : 1704–7. [Google Scholar]
  47. Schwartz MW, Erickson JC, Baskin DG, et al. Effect of fasting and leptin deficiency on hypothalamic neuropeptide Y gene transcription in vivo revealed by expression of a lacZ reporter gene. Endocrinology 1998; 5 : 2629–35. [Google Scholar]
  48. Jochum W, David JP, Elliott C, et al. Increased bone formation and osteosclerosis in mice overexpressing the transcriptin factor fra-1. Nat Med 2000; 6 : 980–4. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.